Suppr超能文献

巴雷特食管高级别异型增生和早期癌的管理:一个多学科问题。

The management of high grade dysplasia and early cancer in Barrett's esophagus. A multidisciplinary problem.

作者信息

Rusch V W, Levine D S, Haggitt R, Reid B J

机构信息

Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021.

出版信息

Cancer. 1994 Aug 15;74(4):1225-9. doi: 10.1002/1097-0142(19940815)74:4<1225::aid-cncr2820740408>3.0.co;2-q.

Abstract

BACKGROUND

The incidence of Barrett's-associated esophageal adenocarcinoma is rising, but experience in the treatment of high-grade dysplasia (HGD) or early cancer is limited. Based on an endoscopic surveillance program, the authors developed a systematic multidisciplinary approach to this problem.

METHODS

Surgical resection was considered if biopsies of the Barrett's segment, performed according to a published protocol, showed invasive cancer, intramucosal carcinoma, or repeated evidence of HGD. The type of resection was based on the length of the Barrett's segment and included an en bloc lymph node dissection for staging purposes. Careful intraoperative pathologic evaluation ensured that all of the Barrett's mucosa was resected.

RESULTS

From 1984 to 1993, 27 consecutive patients (23 men, 4 women), with median age of 61 years (range, 45-75 years) underwent surgical exploration. Indications for operation were invasive cancer in 17 patients, intramucosal carcinoma in 5 patients, and HGD in 5 patients. Median length of the Barrett's segment was 9 cm (range, 1-17 cm). Only 15 patients (55%) had abnormalities visible with endoscopic examination that were potentially suspicious for malignancy. Twenty-six patients underwent resection with complete removal of the Barrett's mucosa, 20 by Ivor Lewis esophagogastrectomy, and 6 by transhiatal esophagectomy. Pathologic tumor stages were: TisN0M0 in 10 patients; T1N0M0 in 11 patients; T2N0M0 in 2 patients; T3N0M0 in 3 patients; and T1NXM1 in 1 patient. There were no postoperative deaths or anastomotic leaks. Major complications occurred in 4 patients. With a median follow-up of 3.7 years, 22 patients were alive, and only 2 patients had recurrences.

CONCLUSIONS

This increasingly important group of patients with HGD or early carcinoma in the Barrett's esophagus has a high chance of cure but requires careful multidisciplinary treatment by the surgeon, gastroenterologist, and pathologist.

摘要

背景

巴雷特食管相关腺癌的发病率正在上升,但高级别异型增生(HGD)或早期癌症的治疗经验有限。基于一项内镜监测计划,作者针对该问题制定了一种系统的多学科方法。

方法

如果按照已发表的方案对巴雷特段进行活检显示为浸润性癌、黏膜内癌或反复出现的HGD证据,则考虑手术切除。切除类型基于巴雷特段的长度,并包括为分期目的进行的整块淋巴结清扫。术中仔细的病理评估确保切除所有巴雷特黏膜。

结果

1984年至1993年,连续27例患者(23例男性,4例女性)接受了手术探查,中位年龄61岁(范围45 - 75岁)。手术指征为17例浸润性癌、5例黏膜内癌和5例HGD。巴雷特段的中位长度为9 cm(范围1 - 17 cm)。只有15例患者(55%)在内镜检查中发现有潜在可疑恶性的异常。26例患者接受了切除手术,巴雷特黏膜完全切除,20例行Ivor Lewis食管胃切除术,6例行经裂孔食管切除术。病理肿瘤分期为:TisN0M0 10例;T1N0M0 11例;T2N0M0 2例;T3N0M0 3例;T1NXM1 1例。无术后死亡或吻合口漏。4例患者发生主要并发症。中位随访3.7年,22例患者存活,仅2例复发。

结论

这一越来越重要的巴雷特食管HGD或早期癌患者群体有很高的治愈机会,但需要外科医生、胃肠病学家和病理学家进行仔细的多学科治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验